GelMA hydrogel enhances diabetic wound healing by delivering shock wave-preconditioned BMSC-derived small extracellular vesicles
- 1Department of Orthopedics, Orthopedics Center, The First Hospital of Jilin University, Jilin University
- 2Department of Sports Medicine, Hubei Sports Medicine Center, Wuhan Fourth Hospital
Abstract
Introduction: Diabetic foot ulcers (DFUs) are chronic, hard-to-heal wounds characterized by impaired angiogenesis, persistent inflammation, and defective extracellular matrix remodeling. Bone marrow mesenchymal stem cell-derived small extracellular vesicles (BMSC-sEVs) hold promise for cell-free therapy; however, their therapeutic efficacy is limited by insufficient reparative bioactivity and rapid local clearance. This study aimed to enhance the intrinsic therapeutic potential of BMSC-sEVs through shock wave preconditioning and improve their local retention and sustained delivery using gelatin methacryloyl (GelMA) hydrogel.
Methods: BMSCs were preconditioned with shock waves, and the resulting small extracellular vesicles (SW-sEVs) were isolated and characterized. Their angiogenic and immunomodulatory effects were evaluated using human umbilical vein endothelial cells (HUVECs) and RAW264.7 macrophages. Proteomic analysis and Western blotting were performed to investigate potential underlying mechanisms. SW-sEVs were subsequently incorporated into a 15% GelMA hydrogel, and the resulting delivery system was characterized. Its therapeutic efficacy was evaluated in a streptozotocin (STZ)-induced hyperglycemic rat wound model.
Results: Shock wave preconditioning did not alter the typical morphology, particle size distribution, or marker protein expression of BMSC-sEVs. Compared with sEVs derived from untreated BMSCs, SW-sEVs significantly enhanced HUVEC proliferation, migration, and tube formation, accompanied by increased VEGFA and CD31 expression. SW-sEVs also suppressed pro-inflammatory macrophage activation, promoted a reparative macrophage phenotype, and reduced the expression of pro-inflammatory factors. Proteomic analysis revealed alterations in sEV protein cargo, with differentially expressed proteins enriched in inflammation-related pathways, including NF-κB signaling. Western blotting further demonstrated reduced phosphorylation of p65 and IκBα following SW-sEV treatment. The 15% GelMA hydrogel exhibited an interconnected porous structure, favorable cytocompatibility, structural stability, and sustained SW-sEV release. In vivo, GelMA-SW-sEVs significantly accelerated diabetic wound healing, enhanced neovascularization and M2 macrophage polarization, reduced local inflammation, and improved re-epithelialization, collagen deposition, and tissue remodeling.
Discussion: Shock wave preconditioning enhances the angiogenic and immunomodulatory activities of BMSC-sEVs, potentially through modulation of NF-κB-related inflammatory signaling. Combined with sustained local delivery using GelMA hydrogel, SW-sEVs demonstrate promising therapeutic potential as a cell-free strategy for diabetic wound repair.
Related
- 3D-Printable and Cytocompatible Hydrogel from Acinetobacter baylyi ADP1 Extracellular Matrix
- M2 Macrophage‐Derived Small Extracellular Vesicle miR‐106a‐Loaded QCG Hydrogel Targets the RNF128‐LXR Pathway to Reprogram Chondrocyte Cholesterol Metabolism for Osteoarthritis Therapy
- Extracellular vesicle-mediated restraint of hepatic CD74–NF-κB repairs diabetic neuropathy
- A light-responsive lipid nanoparticle platform delivering Cas9 RNP for VEGFA editing suppresses choroidal neovascularisation
- Enabling climate action: A nexus approach for delivering co-benefits across biodiversity, water, food, and health
BibTeX
@article{zhou2026gelma,
title = {{GelMA hydrogel enhances diabetic wound healing by delivering shock wave-preconditioned BMSC-derived small extracellular vesicles}},
author = {Rongqi Zhou and Xiaoping Xie and Xudong Li and Songqi Bi and Zhixing Yan and Xiaoyang Zhou and Fanxu Wang and Tiecheng Yu},
journal = {Frontiers in Immunology},
year = {2026},
month = oct,
doi = {10.3389/fimmu.2026.1971302},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1971302/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - GelMA hydrogel enhances diabetic wound healing by delivering shock wave-preconditioned BMSC-derived small extracellular vesicles
AU - Rongqi Zhou
AU - Xiaoping Xie
AU - Xudong Li
AU - Songqi Bi
AU - Zhixing Yan
AU - Xiaoyang Zhou
AU - Fanxu Wang
AU - Tiecheng Yu
PY - 2026
DA - 2026/10/28
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.1971302
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1971302/full
AB - Introduction: Diabetic foot ulcers (DFUs) are chronic, hard-to-heal wounds characterized by impaired angiogenesis, persistent inflammation, and defective extracellular matrix remodeling. Bone marrow mesenchymal stem cell-derived small extracellular vesicles (BMSC-sEVs) hold promise for cell-free therapy; however, their therapeutic efficacy is limited by insufficient reparative bioactivity and rapid local clearance. This study aimed to enhance the intrinsic therapeutic potential of BMSC-sEVs through shock wave preconditioning and improve their local retention and sustained delivery using gelatin methacryloyl (GelMA) hydrogel. Methods: BMSCs were preconditioned with shock waves, and the resulting small extracellular vesicles (SW-sEVs) were isolated and characterized. Their angiogenic and immunomodulatory effects were evaluated using human umbilical vein endothelial cells (HUVECs) and RAW264.7 macrophages. Proteomic analysis and Western blotting were performed to investigate potential underlying mechanisms. SW-sEVs were subsequently incorporated into a 15% GelMA hydrogel, and the resulting delivery system was characterized. Its therapeutic efficacy was evaluated in a streptozotocin (STZ)-induced hyperglycemic rat wound model. Results: Shock wave preconditioning did not alter the typical morphology, particle size distribution, or marker protein expression of BMSC-sEVs. Compared with sEVs derived from untreated BMSCs, SW-sEVs significantly enhanced HUVEC proliferation, migration, and tube formation, accompanied by increased VEGFA and CD31 expression. SW-sEVs also suppressed pro-inflammatory macrophage activation, promoted a reparative macrophage phenotype, and reduced the expression of pro-inflammatory factors. Proteomic analysis revealed alterations in sEV protein cargo, with differentially expressed proteins enriched in inflammation-related pathways, including NF-κB signaling. Western blotting further demonstrated reduced phosphorylation of p65 and IκBα following SW-sEV treatment. The 15% GelMA hydrogel exhibited an interconnected porous structure, favorable cytocompatibility, structural stability, and sustained SW-sEV release. In vivo, GelMA-SW-sEVs significantly accelerated diabetic wound healing, enhanced neovascularization and M2 macrophage polarization, reduced local inflammation, and improved re-epithelialization, collagen deposition, and tissue remodeling. Discussion: Shock wave preconditioning enhances the angiogenic and immunomodulatory activities of BMSC-sEVs, potentially through modulation of NF-κB-related inflammatory signaling. Combined with sustained local delivery using GelMA hydrogel, SW-sEVs demonstrate promising therapeutic potential as a cell-free strategy for diabetic wound repair.
SN - 1664-3224
ER -